Dimensional Fund Advisors’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$97.1K Sell
89,877
-9,896
-10% -$11K ﹤0.01% 3133
2026
Q2
$114K Hold
99,773
– – ﹤0.01% 3129
2026
Q1
$125K Sell
99,773
-21,983
-18% -$27.8K ﹤0.01% 3100
2025
Q4
$149K Sell
121,756
-29,917
-20% -$44.9K ﹤0.01% 3115
2025
Q3
$225K Sell
151,673
-164,214
-52% -$251K ﹤0.01% 3106
2025
Q2
$367K Sell
315,887
-195,831
-38% -$277K ﹤0.01% 3045
2025
Q1
$691K Sell
511,718
-35,579
-7% -$216K ﹤0.01% 2951
2024
Q4
$7.21M Buy
547,297
+91,131
+20% +$1.24M ﹤0.01% 2428
2024
Q3
$5.11M Buy
456,166
+150,844
+49% +$1.89M ﹤0.01% 2513
2024
Q2
$3.28M Buy
305,322
+5,152
+2% +$66.4K ﹤0.01% 2625
2024
Q1
$4.47M Buy
300,170
+146,098
+95% +$2.41M ﹤0.01% 2579
2023
Q4
$2.79M Buy
154,072
+97,420
+172% +$1.48M ﹤0.01% 2718
2023
Q3
$982K Sell
56,652
-74,059
-57% -$1.28M ﹤0.01% 2932
2023
Q2
$2.37M Sell
130,711
-81,745
-38% -$1.94M ﹤0.01% 2728
2023
Q1
$5.65M Buy
+212,456
New +$6.05M ﹤0.01% 2446
2022
Q3
$415K Buy
19,861
+5,154
+35% +$98.6K ﹤0.01% 3083
2022
Q2
$118K Buy
14,707
+1,224
+9% +$7.84K ﹤0.01% 3312
2022
Q1
$95K Buy
+13,483
New +$138K ﹤0.01% 3399

Other funds holding PLRX

Dimensional Fund Advisors's PLRX Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its Pliant Therapeutics (PLRX) stake by 9.9% in Q3 2026, selling an estimated $11K and leaving 89,877 shares worth $97.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3133.

Dimensional Fund Advisors first reported a position in PLRX in Q1 2022 and has held it in 18 quarters since. The position peaked at $7.21M in Q4 2024. 15 funds tracked by Wall St. Rank hold PLRX as of Q3 2026.

  • Dimensional Fund Advisors held 89,877 shares of Pliant Therapeutics worth $97.1K as of Q3 2026.
  • Dimensional Fund Advisors sold 9,896 Pliant Therapeutics shares in Q3 2026, an estimated $11K.
  • Pliant Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #3133 holding.
  • Dimensional Fund Advisors first reported a position in Pliant Therapeutics in Q1 2022 and has held it in 18 quarters since.
  • Dimensional Fund Advisors's Pliant Therapeutics position peaked at $7.21M in Q4 2024.
  • 15 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.